» Articles » PMID: 30741094

Approaches to Photoprotection and Normalization in Highly Adherent Families of Children With Xeroderma Pigmentosum in the United Kingdom

Overview
Journal Qual Health Res
Publisher Sage Publications
Specialty Health Services
Date 2019 Feb 12
PMID 30741094
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

In this study, we examine photoprotection for children with Xeroderma pigmentosum (XP), a rare genetic skin disease requiring rigorous photoprotection, to reduce risks of severe burning and skin cancers from exposure to ultraviolet radiation (UVR). We elicit the views and experiences of both children and their parents to inform the care and support provided. Qualitative semistructured interviews were undertaken with 12 child-parent dyads recruited from the National XP Specialist service in London. We employed a framework approach to analysis. This identified a high level of photoprotection based either on "protection" to facilitate normal activities or "avoidance" of outdoor activity with priority given to normality in the future. These approaches were shaped by perceptions of clinical risk, the emphasis given to a normal family life and families' circumstances and resources. The findings contribute to notions of normalization and coping with demanding care regimens and inform approaches to working with families.

Citing Articles

Translating patient needs into medical device development: co-design of a photoprotection visor for Xeroderma Pigmentosum using qualitative interviews.

Graham T, Sooriah S, Chang Y, Hashimdeen S, Meydan T, Grocott P Orphanet J Rare Dis. 2024; 19(1):64.

PMID: 38351060 PMC: 10865654. DOI: 10.1186/s13023-023-03002-y.


Perceived Social Support, Normalization, and Subjective Well-Being Among Family Members of a Child with Autism Spectrum Disorder.

Hamama L J Autism Dev Disord. 2023; 54(4):1468-1481.

PMID: 36637591 DOI: 10.1007/s10803-022-05857-9.


Improving photoprotection in adults with xeroderma pigmentosum: personalisation and tailoring in the 'XPAND' intervention.

Sainsbury K, Walburn J, Foster L, Morgan M, Sarkany R, Weinman J Health Psychol Behav Med. 2021; 8(1):543-572.

PMID: 34040885 PMC: 8114353. DOI: 10.1080/21642850.2020.1840379.